logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: Therapy
Load new posts () and activity
Like Reblog Comment
text 2021-09-22 09:43
US Anticoagulation Therapy Market worth USD 27.83 Billion : Expand At A Healthy Growth Rate In The Coming Years

According to the new market research report ” US Anticoagulation Therapy Market by Product ((Anticoagulants Drugs (NOACs, Warfarin)), PT/INR Devices (In-Office, Home Testing)), Service Type (Testing & Consulting), Type of Clinic (Hospital Associated, Independent & Pharmacy-based)”, published by MarketsandMarkets™ , US anticoagulation therapy market is projected to reach USD 27.83 Billion by 2022 from USD 17.25 Billion in 2016, at a CAGR of 8.5%.

The market is segmented into products (anticoagulation drugs and PT/INR testing devices) and anticoagulation clinics. The growth in the anticoagulation drugs market is primarily driven by the rising incidence of venous thromboembolism, atrial fibrillation, and stroke; long-term administration and high volume of recurring sales of anticoagulation drugs; and increasing demand for novel oral anticoagulants (NOACs).

Expected Revenue Growth:

[86 Pages Report] The US anticoagulation therapy market is projected to reach USD 27.83 Billion by 2022 from USD 17.25 Billion in 2016, at a CAGR of 8.5%.

Accessories to Fuel the Growth of US Anticoagulation Therapy Market :

In this report, the US anticoagulation therapy market is segmented on the basis of products and clinics. On the basis of products, the market is segmented into anticoagulation drugs and PT/INR testing devices.

Browse in-depth TOC on “US Anticoagulation Therapy Market”

29 – Tables

25 – Figures

86 – Pages

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=114158575  

Based on drug type, the anticoagulation therapy market for drugs is segmented into NOACs, warfarin (VKA), and other drugs. In 2016, the NOACs segment dominated the US anticoagulation therapy market for drugs. Due to the better safety and efficacy of NOACs as compared to traditional therapies, the adoption of NOACs is higher as compared to traditional drugs. In addition, key market players such as Portola Pharmaceuticals (received FDA approval for its NOAC Betrixaban in July 2017) are focusing on the development of NOACs in order to capitalize on the growth opportunities presented by this shift in market dynamics

The anticoagulation therapy market for PT/INR testing devices is segmented into in-office testing devices and home testing devices. The in-office devices segment dominated the US anticoagulation therapy market for PT/INR testing devices. The large share of this segment is mainly attributed to the large number of patients opting for in-office testing services.

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=114158575  

C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), and Portola Pharmaceuticals (US) are the major market players in the global market for drugs while Roche (Switzerland), Abbott (US), Siemens (Germany), Alere (US), and CoaguSense (US) are the major market players in the US anticoagulation therapy market for PT/INR home testing devices.

Source: www.marketsandmarkets.com/Market-Reports/us-anticoagulation-therapy-market-114158575.html
Like Reblog Comment
text 2021-09-15 09:33
Intraoperative Radiation Therapy Market Reach USD 66 Million By 2025 : Technological Advancements in the field of Electron IORT

The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market. Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players.

[159 Pages Report] The global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period.

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Market Dynamics

1. Growing global prevalence of cancer
2. Improving reimbursement scenario
3. Procedural advantages over EBRT
4. Technological advancements

COVID-19 Impact on the global Intraoperative radiation therapy market

The intraoperative radiation therapy market was significantly impacted by the COVID-19 pandemic. Various screening, diagnostic, and surgical procedures were restricted or postponed at hospitals and cancer treatment centers, which resulted in disruptions in the cancer diagnosis as well as treatment market. The pandemic also impacted the availability of healthcare resources. Major regulatory authorities across the globe, such as the CDC, WHO, MHRA, TGA, and EMA, have identified cancer patients at a greater risk of contracting coronavirus disease than healthy adults. In order to reduce the burden on the patient and staff while reducing the risk of exposure, few alternate dose-fractionation regimens were suggested by regulatory authorities.

Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245000083 

The IORT procedure is associated with various advantages such as targeted radiation, limited treatment time, high precision and radiation control, and minimal radiation exposure of normal tissue. This is especially true for breast cancer, as this mode offers women a choice of breast-sparing treatment (lumpectomy). The increasing prevalence of breast cancer is, therefore, a key factor driving the market growth. The growing prevalence of cancer will increase the adoption of IORT procedures.

The geographical regions mapped in the report are:1. North America2. Europe3. Asia-Pacific4. Latin America5. Middle East & Africa

North America, comprising the US and Canada, accounted major share of the intraoperative radiation therapy market in 2019. The major factors driving market growth in this region are the easy availability and high adoption of IORT for cancer treatment, the rising incidence of cancer, and significant per capita annual healthcare expenditure in the US and Canada. Furthermore, associations such as the American Society for Radiation Oncology (ASTRO) have advocated the use of low-energy IORT, which has contributed to its increased adoption in North America..

Some key players mentioned in the research report are:

The major players in the Intraoperative radiation therapy market are ZEISS Group (Germany), iCAD, Inc. (US), Eckert & Ziegler (Germany), Elekta AB (Sweden), GMV Innovating Solutions (Spain), Sensus Healthcare, Inc. (US), IntraOp Medical, Inc. (US), Isoray, Inc. (US), Becton, Dickinson and Company (US), Sordina IORT Technologies (OTCPK:ITALY), Varian Medical Systems, Inc. (US), SeeDos Ltd. (UK), IsoAid LLC (US), Ariane Medical Systems Ltd. (UK), Panacea Medical Technologies Pvt. Ltd. (India), Salutaris Medical Devices (US), Brainlab AG (Germany), RaySearch Laboratories (Sweden), REMEDI Co., Ltd. (South Korea), Merit Medical Systems, Inc. (US), among others.

Request for sample pages @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=245000083

Source: www.marketsandmarkets.com/Market-Reports/intraoperative-radiation-therapy-market-245000083.html
Like Reblog Comment
text 2021-09-13 09:45
Particle Therapy Market Worth USD 1,349 Million by 2023 : Indicates Impressive Growth Rate In Medical Devices Industry

According to the new market research report “ Particle Therapy Market by Type (Heavy Ion, Proton Therapy), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate, Breast), Application (Treatment, Research) – Forecast to 2023“, published by MarketsandMarkets™, global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%.

Exhaustive secondary research was done to collect information on the market and its different subsegments. The study involved four major activities to estimate the current market size for particle therapy. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Major Growth Drivers:

Growth in the particle therapy market is primarily driven by factors such as the various advantages offered by particle therapy over photon therapy, growing global prevalence of cancer, increasing adoption of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide.

Expected Revenue Growth:

The particle therapy market is projected to grow from an estimated USD 865 million in 2018 to USD 1,349 million by 2023, at a CAGR of 9.3% during the forecast period.

Synchrotrons are used to accelerate both protons and heavy ions such as carbon and hydrogen. The growth of the synchrotrons segment is attributed to factors such as the increasing number of research activities as well as the increasing investments in the development of synchrotron facilities.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12809137 

The large share of the proton therapy segment can be attributed to factors such as the high degree of precision, shorter treatment time, and reduced side-effects associated with proton therapy as compared to conventional photon therapies using X-rays. Other factors such as the increasing research activities in the field of radiation oncology using proton therapy systems, rising number of proton therapy centers, and longer equipment lifespan of proton therapy (30 years or more) in comparison to photon therapy (10 years) are expected to support the growth of this market in the coming years.

Asia Pacific is expected to hold a significant share in the particle therapy market during the forecast period

The Asia Pacific is one of the major revenue generating regions in the particle therapy market. China and Japan are the major countries responsible for the high growth of this regional market owing to factors such as the increasing per capita income, improving healthcare infrastructure, and supportive government activities in these emerging countries. Furthermore, the increasing geriatric population, growing incidence of cancer, and rising acceptance of particle therapy procedures and devices are also driving the growth of this regional market.

Request for sample pages :  https://www.marketsandmarkets.com/requestsampleNew.asp?id=12809137 

Source: www.marketsandmarkets.com/Market-Reports/particle-therapy-market-12809137.html
Like Reblog Comment
text 2021-09-06 07:33
A Guide to Couples Coaching - Everything You Need to Know

It

 

Couples coaching involves coaching sessions for a couple, where a therapist will work with both partners to address certain concerns that are preventing true joy and fulfilment in the relationship. This sort of counselling works well regardless of how long the relationship has been going on. Every couple experiences difficulties at one point or another in their relationship and it is important to remember that couples coaching can help them overcome that. 

All about couples coaching 

The goal of this form of coaching is to help individuals set their expectations and desires about a relationship straight. More than that, it helps them make all of that happen. By the end of a couples coaching course, the couple should have a clear understanding of what is difficult in their life together and what their goals should be. The coach will actively work with both partners to develop working solutions. 

 should be pointed out that couples coaching also works on an individual level. It is based on the idea that when a person is feeling fulfilled on their own, they can bring that healthy motivation into a relationship and seek to make it better. That is what people coming to couples coaching sessions have in common – they know they want to make their relationships better and they are not quite sure whether they need to look for improvement in themselves or their partners. 

Difference between counselling and coaching

Couples counselling is all about providing a non-judgmental space for couples to discuss their issues and reveal their emotional wounds. For example, it can help a couple work on restoring trust after a case of infidelity. The goal is to fix an issue that has happened to them and find the best way to move forward. 

Coaching can be similar in that it also provides a non-judgmental space for discussion, but the therapy itself is more action-oriented. There is much less unpacking the past that takes place and more about focusing on what the future goals should be. In that sense, couples coaching is more focused on the present and the future, and not so much on the past. 

Depending on what you want to achieve, you will be able to choose your kind of support wisely. If you think unresolved problems from the past are hindering you, then seek out couples counselling. If you want to change the present problems you have with your partner, then couples coaching might be right. 

What do couples coaching help with? 

Coaching is quite versatile and can aid in many areas of your life. These areas are identified by the couple in the couple’s coaching. It could be before or during sessions. Here are a few examples of areas to work on: 

  • Clarity around obstacles – understanding what stands in your way is always the first step. Relationships don’t often make it easy to know what the problem is. Couples coaching can uncover the real issues and set the tone for working on them. 

  • Better communication – another important aspect of couples coaching lies with improving communication between partners. After all, communication is at the heart of any relationship. If it becomes a stumbling block, then something is wrong. 

  • Aligning visions and values for the future – as people enter a relationship, they bring different values and visions for the future. If they aren’t aligned, that is potential for conflict, which can be remedied with couples coaching. During it, couples can identify their core values and outline the future they want to build upon. 

  • Build mutual understanding – this can be a major problem in long-term relationships. Sometimes partners feel like the other is taking them for granted and need to work on ways to build more appreciation towards one another. 

© Zoe Clews & Associates

 

Like Reblog Comment
text 2021-08-04 07:57
Home Infusion Therapy Market Growth by Global Key Players : ICU Medical Inc & Care Fusion Corporation

The global Home Infusion Therapy Market is anticipated to grow at a significant CAGR during the forecast period. Home infusion therapy is an integral part of professional practice in developed countries. Though the patients’ scenarios are different under various circumstances, a considerable amount of risk is always involved. The nature of home infusion therapy is not only limited to patient care and device, but also it actively involves accumulation of consumables and enactment of quality improvement and research activities.

 

Free Exclusive Sample of this Report @ https://bit.ly/3CdN6FP

 

 

Driving factors for home infusion therapy market include rise in geriatric population and availability of medical attention under a strong infrastructure. Apart, homecare therapies/home infusion therapies are gaining a significant traction in the low income regions since medical needs are unavailable during emergencies. Medical practices inclined towards patient betterment are expected to gain a huge traction in the forecast period. However, expensive nature of home infusion therapy might challenge the market demand. Product segment for home infusion therapy market includes infusion pump sets, IV cannulas and needleless connectors. Application segment includes endocrinology, parenteral nutrition, and hydration therapy.

 

Geographical segmentation for home infusion therapy market includes North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America accounts for a significant market share in the forecast period due to rise in government support and advances in medical technology. Medical benefits offered by government in these regions are likely to trigger the market growth.

 

Asia-Pacific regions are likely to grow at a significant share in the global market due to presence of medical infrastructure and rise in patient awareness. The homecare therapies are gaining traction due to emphasis on patient betterment and proper medical attention for geriatric patients. The key players in the home infusion therapy industry include Baxter, B.Braun Melsungen AG, Caesarea Medical Electronics, ICU Medical Inc, Care Fusion Corporation, Fresenius Kabi AG, Terumo Corporation, Smiths Medicala and JMS Co Ltd.

 

Browse Full Report With TOC @ https://bit.ly/3jkhhCT

 

Market Segment:

Product Outlook (Market revenue in USD Million, 2013 - 2024)
    • Infusion pumps
        • Ambulatory infusion pumps
        • Insulin pumps
        • Syringe pumps
        • Elastomeric pumps
        • Patient Controlled Analgesics (PCA)
    • Intravenous Sets
    • IV Cannulas
    • Needleless Connectors

 

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

 

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email:ryan@millioninsights.com

More posts
Your Dashboard view:
Need help?